Introduction.

The consumption of psychoactive substances (SPA) is considered a chronic disease because the onset, course, direction, and result is unpredictable in some cases and additionally they are multi-causal disorders such as depression; according to data reported by the Barcelona Addiction Center "the incidence of depression in patients with substance abuse ranges between 6% and 70% in SPA users". With this outlook, it should be understood that the intervention should develop the promotion of health and the prevention of disease, with the appearance of biotechnology with the use and application of information and communication technologies (ICT) in science, health and life for diagnosis, prevention, supervision, treatment.

Objective.

To develop a software that allows generating an alert for the early identification of depression associated with the use of psychoactive substances in adults, through the use of a previously validated ICT, during 2019.

Methodology.

Technological Research, using the "UWE "With a focus on software development for the web domain.

Results.

In this research proposal, progress will be made in the development of the product prototype for the early identification of depression in order to improve the clinical decision-making process, at the moment of care, based on the registered information in the software called MEASDEP (Measurement of depression in SPA consumers).

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )